Cell therapies in clinical trials: Moving the needle forward
Breakthrough T1D believes that novel cell therapies in the clinical pipeline will transform T1D management, and Project ACT is how…
Could drugs like Ozempic also benefit people with type 1 diabetes?
Learn more about GLP-1 therapies and SGLT inhibitors, and how drugs like Ozempic may one day be able to help…
From unexpected diagnosis to DIAGNODE-3 participant
Katie Howell was diagnosed with type 1 diabetes last year at age 25. Now, she's the first DIAGNODE-3 trial participant…
ATTD 2025: Closing the loop to cures
At ATTD 2025, Breakthrough T1D led sessions showcasing advancements in T1D cell therapies, early detection, and technology to improve lives.
From Breakthrough T1D trainee to Principal Investigator: Kelsey Voss, Ph.D., is calling the shots
Kelsey Voss, Ph.D., received Breakthrough T1D's Advanced Postdoctoral Fellowship Award, which helped start her lab at UVA studying T cells…
Challenges and solutions: The present and future of cell therapies for T1D
Breakthrough T1D is funding research that supports manufactured islet cell source, survival, and protection and is also driving initiatives to…
Medical Affairs: Closing the gap between access and adoption
Breakthrough T1D's new Medical Affairs unit will address the numerous challenges contributing to the slow adoption of groundbreaking T1D therapies.
Nobel laureates, women, and diabetes discoveries
Gerty Cori, Ph.D., Dorothy Crowfoot Hodgkin, FRS, and Rosalyn Yalow, Ph.D., won the Nobel Prize for diabetes discoveries.
What is autoimmune disease?
Learn the basics about autoimmune disease, including prevalence in the U.S., possible causes, and why they are often called "invisible."
Shining the spotlight on Breakthrough T1D scientist Dr. Cassandra Bazile
Dr. Cassandra Bazile is a scientist at Breakthrough T1D who champions community, mentorship, and inclusion in STEM.
